26 July 2016

NICE, Level 1A, City Tower, Piccadilly Plaza, Manchester

The meeting will start promptly at 10:00 and is expected to finish at approximately 17:30

Please note that this agenda is a draft and is subject to change prior to the meeting.

Final agenda

  1. Welcome and introduction to format of meeting – Part 1 only (open session)
  2. Apologies – Part 1 only (open session)
  3. Any other business – Part 1 only (open session)
  4. Topic session – Appraisal of Radium-223 dichloride for treating metastatic hormone relapsed prostate cancer with bone metastases (review of TA376)
    • 4.1. Declarations of interest – Part 1 only (open session)
    • 4.2. Introduction by Amanda Adler – Part 1 only (open session)
    • 4.3. Presentation by Amanda Adler – Part 1 AND part 2 (open and closed session)
    • 4.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)
  5. Topic session – Appraisal of Sorafenib for advanced hepatocellular carcinoma (review of TA189)
    • 5.1. Declarations of interest – Part 1 only (open session)
    • 5.2. Introduction by Amanda Adler – Part 1 only (open session)
    • 5.3. Presentation by Amanda Adler – Part 1 AND part 2 (open and closed session)
    • 5.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)
  6. Topic session – Appraisal of Everolimus in combination with exemestane for treating advanced HER2-negative hormone-receptor-positive breast cancer after endocrine therapy (review of TA295)
    • 6.1. Declarations of interest – Part 1 only (open session)
    • 6.2. Introduction by Amanda Adler – Part 1 only (open session)
    • 6.3. Presentation by Amanda Adler – Part 1 AND part 2 (open and closed session)
    • 6.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)

Date, time and venue of next meeting

Thursday 29 September July 2016, 10:00 at NICE, Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT.

Please note all timings are approximate.

To print this agenda, please right click and select ‘Print’ from the menu

To register

You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.

The closing date for registration is 12 July 2016. Please note that it may not be possible to accept late registration requests. 

Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Jon Littler.

Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email nice@nice.org.uk.Further information about conducting research is also available in our Common Questions and Answers about meetings in public document

 

Registration period: 28 June 2016 to 12 July 2016
Registration is closed.